UFLEX Limited — Investor Meet, 21-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

UFlex started FY27 strong: Q1 consolidated revenue jumped 38% YoY to ₹5,397.2 Cr, with EBITDA up 92% to ₹919.8 Cr (17% margin), and PAT at ₹423.3 Cr. Overseas operations and value-added products fueled this growth. Management is confident this strong momentum is sustainable, projecting 35% revenue and EBITDA growth for FY27. Major capex projects like the Egypt Aseptic plant and Mexico WPP facility are coming online, set to drive significant growth and margin improvement through FY29. The company emphasizes a derisked global model and debt reduction, with Debt-EBITDA targeting below 3x by FY28.